Robert C. Wallach

1.5k total citations
55 papers, 1.1k citations indexed

About

Robert C. Wallach is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert C. Wallach has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Reproductive Medicine, 16 papers in Obstetrics and Gynecology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert C. Wallach's work include Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Prenatal Substance Exposure Effects (6 papers). Robert C. Wallach is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Prenatal Substance Exposure Effects (6 papers). Robert C. Wallach collaborates with scholars based in United States, Netherlands and Mexico. Robert C. Wallach's co-authors include George Blinick, Eulogio Jerez, B Kabakow, Howard W. Bruckner, Carmel J. Cohen, Gunter Deppe, James F. Holland, Luigi Mastroianni, S.B. Gusberg and Judith D. Goldberg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Medicine.

In The Last Decade

Robert C. Wallach

54 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert C. Wallach United States 17 378 348 223 205 186 55 1.1k
Seppo Kivinen Finland 21 272 0.7× 230 0.7× 153 0.7× 152 0.7× 134 0.7× 65 1.1k
Katsuyoshi Seki Japan 18 148 0.4× 349 1.0× 207 0.9× 303 1.5× 132 0.7× 73 1.1k
P. f. Bolis Italy 18 227 0.6× 154 0.4× 222 1.0× 231 1.1× 72 0.4× 45 996
J.G. Grudzinskas United Kingdom 18 451 1.2× 158 0.5× 137 0.6× 375 1.8× 72 0.4× 48 1.1k
Maclyn E. Wade United States 18 271 0.7× 366 1.1× 156 0.7× 458 2.2× 54 0.3× 39 1.2k
Giuseppe Pelusi Italy 25 519 1.4× 268 0.8× 181 0.8× 314 1.5× 161 0.9× 64 1.6k
Alex Rabinovich Israel 19 287 0.8× 105 0.3× 238 1.1× 78 0.4× 207 1.1× 70 1.1k
Yoram Z. Diamant Israel 21 284 0.8× 438 1.3× 166 0.7× 364 1.8× 23 0.1× 94 1.3k
Angeliki Sarandakou Greece 18 221 0.6× 175 0.5× 69 0.3× 266 1.3× 129 0.7× 75 1.0k
Aris Antsaklis Greece 24 266 0.7× 334 1.0× 261 1.2× 362 1.8× 110 0.6× 104 1.6k

Countries citing papers authored by Robert C. Wallach

Since Specialization
Citations

This map shows the geographic impact of Robert C. Wallach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Wallach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Wallach more than expected).

Fields of papers citing papers by Robert C. Wallach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Wallach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Wallach. The network helps show where Robert C. Wallach may publish in the future.

Co-authorship network of co-authors of Robert C. Wallach

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Wallach. A scholar is included among the top collaborators of Robert C. Wallach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Wallach. Robert C. Wallach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwa, Maryann, et al.. (2013). Ovarian Cancer in BRCA Mutation Carriers: Improved Outcome After Intraperitoneal (IP) Cisplatin. Annals of Surgical Oncology. 21(5). 1468–1473. 26 indexed citations
2.
Andreopoulou, Eleni, Tai C. Chen, Leonard Liebes, et al.. (2010). Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer. Cancer Chemotherapy and Pharmacology. 68(2). 457–463. 9 indexed citations
3.
Pasquina, Paul F., et al.. (2010). Upper Limb Nerve Entrapment Syndromes in Veterans With Lower Limb Amputations. PM&R. 2(1). 14–22. 7 indexed citations
4.
Wallach, Robert C., Joan Cangiarella, Guoping Cai, et al.. (2009). Origin, Frequency and Clinical Significance of Glandular Cells in Liquid-Based Pap Tests from Patients Posthysterectomy. Acta Cytologica. 53(1). 1–9. 2 indexed citations
5.
Höchster, Howard S., Elizabeth R. Plimack, John Mandeli, et al.. (2005). Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: An NYGOG and ECOG study. Gynecologic Oncology. 100(2). 324–329. 8 indexed citations
6.
Mesia, Augusto F., et al.. (2000). Xanthogranulomatous Tubo-Ovarian Abscess Resulting from Chronic Diverticulitis. Gynecologic and Obstetric Investigation. 49(1). 70–72. 19 indexed citations
8.
Höchster, Howard S., Scott Wadler, Carolyn D. Runowicz, et al.. (1999). Activity and Pharmacodynamics of 21-Day Topotecan Infusion in Patients With Ovarian Cancer Previously Treated With Platinum-Based Chemotherapy. Journal of Clinical Oncology. 17(8). 2553–2553. 74 indexed citations
9.
Wadler, Scott, Edward L. Schwartz, Hilda Haynes, et al.. (1997). All-trans retinoic acid and interferon-?-2a in patients with metastatic or recurrent carcinoma of the uterine cervix. Cancer. 79(8). 1574–1580. 16 indexed citations
10.
Speyer, James L., John Mandeli, Howard S. Höchster, et al.. (1995). A Phase I Trial of Cyclosphosphamide and Carboplatinum Combined with Interleukin-3 in Women with Advanced-Stage Ovarian Cancer. Gynecologic Oncology. 56(3). 387–394. 8 indexed citations
11.
Mittal, Khush, et al.. (1995). Coexistent atypical polypoid adenomyoma and endometrial adenocarcinoma. Human Pathology. 26(5). 574–576. 17 indexed citations
12.
Rorat, Edwarda & Robert C. Wallach. (1990). Endometrioid carcinoma of the fallopian tube: Pathology and clinical outcome. International Journal of Gynecology & Obstetrics. 32(2). 163–167. 7 indexed citations
13.
Romaguera, Josefina, et al.. (1990). Acceleration of Fetal Maturation with Intra‐Amniotic Thyroxine in the Presence of Maternal Malignancy. Acta Obstetricia Et Gynecologica Scandinavica. 69(3). 229–234. 6 indexed citations
14.
Romaguera, Josefina, et al.. (1990). Responsiveness of L‐S Ratio of the Amniotic Fluid To Intra‐Amniotic Administran of Thyroxine: Role of fetal age. Acta Obstetricia Et Gynecologica Scandinavica. 69(2). 119–122. 7 indexed citations
15.
Adamsons, Karlis & Robert C. Wallach. (1989). Single Cause for Initiation of Labor and Toxemia: A Hypothesis. American Journal of Perinatology. 6(2). 133–137. 3 indexed citations
16.
Wallach, Robert C.. (1987). Inflammatory and neoplastic diseases of the vulva. Clinics in Dermatology. 5(2). 66–76.
17.
Wallach, Robert C., et al.. (1983). Meiotic chromosomal changes and sterility produced by nitrogen mustard and procarbazine in mice. Fertility and Sterility. 39(1). 97–102. 8 indexed citations
18.
Bruckner, Howard W., Carmel J. Cohen, Judith D. Goldberg, et al.. (1981). Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin. Cancer. 47(9). 2288–2294. 92 indexed citations
19.
Wallach, Robert C.. (1972). Dextran therapy for pregnancy-associated deep thrombophlebitis. American Journal of Obstetrics and Gynecology. 112(5). 613–618. 3 indexed citations
20.
Wallach, Robert C.. (1957). Emboli Arising in the Lungs. Archives of Internal Medicine. 99(1). 142–142. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026